Skip to main content
. 2025 May 7;18:27–38. doi: 10.2147/LRA.S515510

Table 3.

Descriptive Statistics of Items from the International Pain Outcomes Questionnaire

Baseline Characteristics Control Group DEX Group DEM Group p-value
Postoperative day 2 Pain Outcomes Questionnaire score
Intensity
Worst pain a 6.2 (4.8,7.2) 6.5 (5.0,7.8) 7.0 (5.7,9) 0.183
Percent time in severe pain b 35 [20,40]{10,80} 20 [10,30]{10,50} 20 [10,40]{10,60} 0.461
Percent pain relief b 70 [30,50]{5,80} 90 [55,30]{10,90} 90 [70,90]{50,90} 0.857
With activities in bed a 0 [0,3]{0,7} 1 [0,4]{0,6} 0 [0,2]{0,5} 0.518
With breathing/coughing a 0 [0,0]{0,4} 1 [0,2]{0,6} 0 [0,0]{0,1} 0.619
With sleep a 0 [0,3]{0,7} 1 [0,4]{0,8} 0 [0,3]{0,8} 0.418
Effect on emotions
Anxiety a 0 [0,4]{0,6} 0 [0,3]{0,9} 0 [0,1]{0,8} 0.241
Helplessness a 0 [0,3]{0,9} 0 [0,2]{0,4} 0 [0,1]{0,5} 0.266
Side effects
Respiratory depression 0 0 0 1
Acute urinary retention 0 1 (3.3%) 0 1
Nausea a 2 [0,4]{0,9} 0 [0,2]{0,4} 0 [0,3]{0,8} 0.167
Vomiting 6 (20%) 2 (6.6%) 3 (10%) 0.366
Drowsiness a 0 [0,2]{0,8} 0 [0,1.5]{0,4} 0 [0,2]{0,3} 0.710
Itching a 0 [0,0]{0,1} 0 [0,0]{0,0} 0 [0,0]{0,0} 0.445
Dizziness a 0 [0,5]{0,9} 0 [0,2]{0,5} 0 [0,2]{0,3} 0.765
Allowed to participate in decision about pain treatment as much as desired
15 (50%) 16 (53.3%) 16 (53.3%) 1
Desire for more treatment 12 (40%) 5 (16.7%)* 4 (13.3%)* 0.042
Overall satisfaction with pain management a 9 [7,9]{7,10} 9 [8,10]{5,10} 9 [9,10]{6,10} 0.677
Satisfied with results of pain treatment 0–24 h a 9 [8.5,10]{7,10} 10 [9.5,10]{9,10}* 10 [9,10]{7,10} 0.036
Satisfied with results of pain treatment 24–48 h a 9 [8,9]{7,10} 9 [9,10]{5,10} 10 [8,10]{6,10} 0.061
Patients reporting chronic pain and receipt of opioids before admission to hospital
How severe was the chronic pain most of the time?
4.8 (3.1,8.4) 5.0 (3.0,7.1) 5.2 (3.3,7.2) 0.819
Worst pain after surgery 7.5 (5.5,7.7) 5.8 (4.4,6.5) 6.2 (4.1,7.0) 0.236
Patients with no report chronic pain and no receipt of opioids before admission to hospital
Worst pain after surgery 5.2 (4.0,7.4) 5.5 (4.0,6.6) 5.8 (3.8,7.1) 0.752
Postoperative neurologic symptoms§
2 weeks postoperative 4 (13.3%) 8 (26.7%) 6 (20%) 0.429

Notes: Data are expressed as the median [IQR]{range}, mean (95% CI), or count (percent). aAssessed using a 0–10 numerical rating scale scale. bAssessed using a percentage scale. *Statistically significant different compared to the Control group. §The postoperative neurologic symptoms include any one or more cases of transient or persistent numbness or paresthesia anywhere in the surgical limb, or pain or weakness in the foot or ankle.

Abbreviations: DEX, dexamethasone; DEM, dexmedetomidine; 95% CI, 95% confidence interval; AUC, area under the curve.